World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2016
Main ID:  NCT02433301
Date of registration: 29/04/2015
Prospective Registration: No
Primary sponsor: Rikshospitalet University Hospital
Public title: PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy
Scientific title: PET/MR-imaging and Circulating Tumour Cells to Evaluate the Response of Chemotherapy in Patients With Gastroesophageal Junction Cancer
Date of first enrolment: April 2015
Target sample size: 23
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02433301
Study type:  Observational
Study design:  Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with histologically verified adenocarcinoma of the Gastroesophageal junction
and assessed as operable.

Exclusion Criteria:

- Under 18 of age

- Not given informed consent

- Other histological cancers besides adenocarcinoma

- Metal in the body that would contraindicate MR-imaging

- Allergies for contrast

- Claustrophobia

- Not a candidate for perioperative chemotherapy and surgery



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Gastroesophageal Junction Cancer
Intervention(s)
Primary Outcome(s)
To Study wether molecular PET/MR-imaging can measure a significant difference between responders and non-responders receiving perioperative chemotherapy [Time Frame: 8 Months]
Secondary Outcome(s)
To examine if DWI and ADC can identify lymph nodes suspected for malignancy and correlate these with findings from the resected tumour preparation [Time Frame: 8 Months]
To correlate a possible difference in responders and non-responders to survival, disease progression prior to surgery, inoperability, surgical complications and tolerance of both preoperative- and postoperative chemotherapy [Time Frame: 8 Months]
Secondary ID(s)
H-1-2014-076
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history